Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Qiagen ( (QGEN) ) has issued an announcement.
QIAGEN N.V. reported that the Dutch financial regulator AFM has notified the company of a substantial shareholding disclosure by DWS Investment GmbH. As of a transaction dated January 15, 2026, DWS holds 3,472,225 ordinary shares in QIAGEN, representing a 1.68% capital interest and 3.06% of the voting rights, all held directly and on a real basis. The notice, drawn from the AFM’s public register, underscores ongoing institutional investor interest in QIAGEN’s stock and provides shareholders with updated transparency on the company’s ownership structure, although QIAGEN emphasized it is not responsible for the accuracy of the AFM filing itself.
The most recent analyst rating on (QGEN) stock is a Buy with a $62.00 price target. To see the full list of analyst forecasts on Qiagen stock, see the QGEN Stock Forecast page.
More about Qiagen
QIAGEN N.V., based in Venlo, the Netherlands, is a life sciences company whose shares are listed on multiple European exchanges as well as the NYSE and Swiss markets, giving it broad international investor exposure.
Average Trading Volume: 1,650,733
Technical Sentiment Signal: Buy
Current Market Cap: $11.47B
Learn more about QGEN stock on TipRanks’ Stock Analysis page.